Search

Search Results for "Astellas"

A Case of Optic Pit Maculopathy thumbnail

A Case of Optic Pit Maculopathy

Matthew Cunningham, MD, FASRS

Two Years of Treatment with Avacincaptad Pegol thumbnail

Two Years of Treatment with Avacincaptad Pegol

Arshad M. Khanani, MD, MA

Real-world GA Case: Pair of Real-world GA Cases Treated with Avacincaptad Pegol thumbnail

Real-World GA Case: Pair of Real-world GA Cases Treated with Avacincaptad Pegol

David Almeida, MD, PhD, MBA

Thumbnail for ftciv

Gene Therapy for Wet AMD

Szilárd Kiss, MD

Alcon Voyager DSLT Fully Launched in US

Posterior Segment Company Updates

ASRS ’24: ACP in Patients with Major EZ Attenuation, and GALE Microperimetry Findings

Katherine Talcott, MD; and Sunir Garg, MD

GA Options in Clinical Therapy, Part 2: Real-World Cases in GA

David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD

GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment Strategies

David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD

GLP-1s and Risk of Age-Related Ocular Disease

Rates of Ocular AEs After Faricimab Injection

Maura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD

GA Options in Clinical Therapy: Which Patients Are a Fit for GA Treatment?

John Kitchens, MD; Saradha Chexal, MD; and Geeta Lalwani, MD

The State of Geographic Atrophy Around the Globe: Part 2 of 2

Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD

Fellow Eye RRD Risk per IRIS Registry

Barton Blackorby, MD; Louis Cai, MD; and Hong-Uyen Hua, MD

The State of Geographic Atrophy Around the Globe: Part 1 of 2

Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD

GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

John Kitchens, MD, Miguel Busquets, MD, and Esther Kim, MD

View More